west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "慢性乙肝病毒携带者" 2 results
  • The Relationship between Pathological Feature of Liver Biopsies and Serological Markers of Bhepatitis in Patients with Chronic Asymptomatic Hepatitis B Carrier

    摘要:目的:分析慢性乙肝病毒携带者肝组织病理与年龄、病程、血清学及肝脏免疫组化指标的相关性,以确定孰是对病理进程影响最主要的指标。方法:对134例临床诊断的慢性乙肝病毒携带者进行乙肝血清学标志物、肝功能、肝活组织病理及免疫组化的检查。结果:①病理表现为不典型增生者HBeAg阴性组少于HBeAg阳性组,而表现为慢性肝炎者前者多于后者,差异均有显著性;HBVDNAlt;105亚组分析两组病理表现无统计学差异;两种病理表现类型在年龄18~40岁组及gt;40岁组明显多于lt;18岁,差异均有显著性;两种病理类型在免疫组化双阳性组均多于单阳性组及全阴

    Release date:2016-09-08 09:56 Export PDF Favorites Scan
  • Effects of Shenlingcao Oral Liquid on 64 Asymptomatic Chronic Hepatitis B Virus Carriers: A Self Control Before-after Trial

    ObjectiveTo observe intervention effect of Shenlingcao oral liquid on asymptomatic chronic hepatitis B virus carriers (AsC). MethodsA self control before-after trial was conducted in the First Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine and the Ninth People's Hospital of Nanchang City from November 2011 to May 2012. A total of 64 AsCs were treated by Shenlingcao oral liquid (1 bottle/d, 200 mL, once daily for 6 months). Serum HBV viral load, six specific serum markers of HBV and 11 liver function index were tested and recorded before and at the 1th, 3th, 6th months of the treatment. Analysis of variance of repeated data was conducted. ResultsAfter one month of the treatment, 35/57 (61.40%) AsCs' serum HBV-DNA loads decreased, 1 log decrease was observed in 15 cases, 2 log decrease was observed in 4 cases, and decrease under the detection limit was observed in 12 cases. 41/57 (71.93%) AsCs' serum HBV-DNA loads decreased after 3 months of treatment, 1 log decrease was observed in 21 cases, 2 log decrease was observed in 5 cases, and decrease under the detection limit was observed in 15 cases. 31/49 (63.26%) AsCs' serum HBV-DNA loads decreased after 6 months of the treatment, 1 log decrease was observed in 19 cases, decrease more than 2 log was observed in 7 cases, and decrease under the detection limit was observed in 12 cases. The serum HBV viral loads at different time points of the treatment were significantly different (P<0.001). As medication time went, AsCs' serum HBV viral loads presented a decrease trend after taking Shenlingcao oral liquid, especially obvious at the 3th month. ConclusionShenlingcao oral liquid could help promote AsCs' ability of clearing virus and controlling serum HBVDNA loads.

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content